13TH ANNUAL · N20 SUMMIT

NEUROSCIENCE20

[ Brain, Spine and Mental Health ]

A Global Platform for NeuroTech (PharmaTech, MedTech, CellTech, BioTech, AITech, and FinTech) Policy and Innovation

December 13, 2026 · Miami, Florida · USA Aligned with G20 Miami 2026

Neuroscience20 is a joint initiative of SBMT and WBMF, advancing brain, spine, and mental health through science, policy, technology, education, global collaboration, and patient impact.

JOINT SBMT AND WBMF INITIATIVE

Science, policy and nonprofit mission working together

Neuroscience20 is a joint initiative of the Society for Brain Mapping and Therapeutics and the World Brain Mapping Foundation. SBMT provides the scientific, clinical, engineering, innovation and policy leadership. WBMF supports the 501(c)(3) nonprofit mission of education, global collaboration, patient impact, public awareness and public-benefit brain health advancement.

BrainSpineMental HealthAINeurotechnologyPatient Impact
AttendFor physicians, scientists, policymakers, nonprofit leaders, students, innovators and patient-impact advocates.
PartnerFor organizations aligned with brain, spine, mental health, AI, neurotechnology, policy and education.
SponsorFor mission-aligned companies and foundations seeking visibility with global brain health leaders.
Support WBMFFor donors and collaborators who want to advance the nonprofit mission behind global brain health.
Leaders at the G20 summit in Toronto during the opening plenary session
GLOBAL POLICY FORUM

What Is the G20?

Visit the Official G20 Website

The Group of Twenty (G20) is an intergovernmental forum that brings together the world's major economies to coordinate dialogue on economic stability, sustainable development, innovation and shared global challenges.

G20 Engagement Groups
B20Business 20 — business community
S20Science 20 — scientific academies and experts
C20Civil 20 — civil society
T20Think 20 — think tanks and policy research

These engagement groups provide structured stakeholder input and policy recommendations to the G20 process.

G20-ALIGNED NEUROSCIENCE

Neuroscience20 (N20)

Neuroscience20 brings brain, spine and mental health into the global policy conversation, connecting policymakers, scientists, clinicians, engineers, investors and industry leaders around translation, innovation and clinical impact.

Launched in 2014 by the Society for Brain Mapping & Therapeutics, N20 is now presented as a joint SBMT and WBMF initiative. It aligns with the U.S. BRAIN Initiative and works across neuroscience, neurotechnology, AI, therapeutics, education, global collaboration, patient impact and health policy.

BrainSpineMental HealthNeuroTech
N20 ARCHIVE

N20 Media

Selected N20 archive videos for delegates, policymakers, researchers and invited participants.

N20 video preview
N20 Video — N20 Archive
N20 video preview
N20 Video — Featured Summit Presentation
N20 Global Brain Health Blueprint (Gemini AI Podcast)
DECEMBER 13, 2026 · MIAMI

N20 Summit Leadership

The 2026 Neuroscience20 Summit brings together the senior leadership guiding the summit across medicine, science, policy, and technology.

20 Featured Leaders
4 Summit Leaders
16 Additional Panelists

President of the Neuroscience20 (N20) Summit

Portrait of Babak Kateb N20 Summit President

Founding Chairman, Director & CEO, SBMT

Babak Kateb MD, PhD

Full profile

Founding Chairman of the Board, Director, and CEO of the Society for Brain Mapping and Therapeutics, which he established in 2004 as a research fellow at USC’s Keck School of Medicine, Department of Neurosurgery, alongside Farzad Massoudi and Warren Grundfest. He also serves as President and Scientific Director of the World Brain Mapping Foundation, Director of the National Center for Nano-Bio-Electronics, and a director of the Brain Technology Innovation Park. He previously led research and development in neurosurgery at the City of Hope Comprehensive Cancer Center, where he pioneered a NASA-derived carbon nanotube technique for brain cancer immunotherapy that earned him a NASA Tech Brief Award. His ongoing collaborations with NASA/JPL and Los Alamos National Laboratory apply AI, augmented and virtual reality, and advanced ultrasonic technology to brain mapping and therapeutics. He has been recognized by then Vice President Biden, the Mayor of Los Angeles, and the Governor of California, received SBMT and WBMF’s Pioneer in Medicine Award in 2015, and edited the inaugural Textbook of Nanoneuroscience and Nanoneurosurgery and Neurophotonics and Brain Mapping.

Senior Executive Vice Chairman, SBMT

Portrait of Dr. Kuldeep Singh Sidhu, PhD N20 Co-Founder

N20 Co-Founder & 11th President, Society for Brain Mapping and Therapeutics

Kuldeep Singh Sidhu PhD

Full profile

Dr. Kuldeep Singh Sidhu, PhD is a professor at UNSW Sydney and a researcher whose work has contributed to the development and translation of stem cell and regenerative medicine technologies. His academic career spans biomedical research, stem cell biology, tissue regeneration, and the advancement of therapeutic approaches for damaged and diseased tissues.

Dr. Sidhu is also the 11th President of the Society for Brain Mapping and Therapeutics, reflecting a long-standing commitment to interdisciplinary collaboration across neuroscience, medicine, biotechnology, and translational research. As a co-founder of the Neuroscience20 (N20) platform, he brings an international scientific perspective to the summit’s mission of connecting neuroscience research with healthcare innovation and global policy.

Portrait of Vicky Yamamoto Senior Executive Leadership

Cancer Science & Developmental Neurobiology

Vicky Yamamoto PhD

Full profile

Dr. Vicky Yamamoto is a cancer scientist at the Keck School of Medicine of USC in the Department of Otolaryngology and Head and Neck Surgery. Before joining USC, she worked at Mount St. Mary’s College, The Scripps Research Institute, the Maxine Dunitz Neurosurgical Institute at Cedars-Sinai Medical Center, and the California Institute of Technology. She received her PhD in biochemistry and molecular biology from the Keck School of Medicine of USC. Her publications have appeared in major journals including Cell, Developmental Cell, Cell Reports, PLOS ONE, NeuroImage, and Oral Oncology, and she has written several book chapters. Her current research and expertise span developmental neurobiology, cell signal transduction, cancer stem cells, molecular targeted therapy, small-molecule screening for cancer treatment, tissue-bank development, and clinical trials. She also serves as Executive Director of the Society for Brain Mapping and Therapeutics.

Portrait of Stefano M. Sinicropi, MD 24th President of SBMT

24th President, Society for Brain Mapping and Therapeutics

Stefano M. Sinicropi MD

Full profile

Dr. Stefano M. Sinicropi serves as the 24th President of the Society for Brain Mapping and Therapeutics, bringing together surgical excellence, executive leadership, innovation, and a deeply patient-centered vision for the future of brain, spine, and whole-person health.

He is a board-certified orthopedic spine surgeon and President and CEO of Midwest Spine & Brain Institute, where he leads a comprehensive orthopedic and neurosurgical spine practice serving patients across Minnesota and the Midwest. He has performed more than 4,000 spinal surgeries across complex spine care, including minimally invasive surgery, deformity, cervical pathology, tumors, and infection.

Since 2012, Dr. Sinicropi has served as President and CEO of Midwest Spine & Brain Institute, helping guide practice growth, physician recruitment, operational development, and healthcare partnerships. His professional interests also extend into regenerative and longevity medicine; he is the founder of Hypercharge Health and co-founder of InSitu Biologics. He is also the author of Wellness at the Speed of Light and an educator on regenerative medicine, longevity science, metabolic health, and the future of healthcare.

Dr. Sinicropi earned his MD from Columbia University College of Physicians and Surgeons, completed his orthopedic surgery residency at Columbia University, and completed the Kenton D. Leatherman Spine Fellowship at the University of Louisville. As SBMT’s 24th President, he brings a strong clinical and strategic voice to the Society’s mission across brain mapping, neurotechnology, therapeutics, spine care, regenerative medicine, education, and interdisciplinary collaboration.

Co-Chairs of the Local Organizing Committee

Portrait of Susan C. Pannullo Co-Chair

Neuro-Oncology & Radiosurgery

Susan C. Pannullo MD, FAANS, FAAN, FCNS

Full profile

Susan C. Pannullo, MD, FAANS, FAAN, FCNS is a double board-certified neurologist and neurosurgeon with subspecialty expertise in neuro-oncology and stereotactic radiosurgery. Her career bridges medicine, neuroscience, and engineering, and she holds academic appointments in Neurosurgery at Columbia University in New York and Biomedical Engineering at Cornell University in Ithaca. As founder and leader of the New York Brain Tumor Project, Dr. Pannullo directed NewYork-Presbyterian/Weill Cornell Medicine’s Neuro-Oncology and Brain and Spine Radiosurgery programs for more than two decades. Her career has encompassed clinical care, translational research, education, clinical trials, biomedical innovation, and academic leadership. She is a recognized advocate for quality and patient safety and was named a 2026 Castle Connolly Top Doctor and Exceptional Woman in Medicine. Dr. Pannullo received her undergraduate degree with honors in Anthropology from Cornell University and her medical degree from Cornell University Medical College. Following an internship at Harvard/Beth Israel Medical Center, she completed residency training in Neurology at New York Hospital/Cornell Medical Center and an American Cancer Society fellowship in Neuro-Oncology at Memorial Sloan Kettering Cancer Center. She subsequently completed a second residency in Neurological Surgery at New York Hospital/Cornell and Memorial Sloan Kettering, becoming the program’s first female graduate. She is also a graduate of the Executive Leadership in Academic Medicine (ELAM) fellowship. Dr. Pannullo’s research and innovation interests include brain tumors, stereotactic radiosurgery, advanced imaging, biomedical engineering, and the development of novel technologies for neurological disease. Her early laboratory research at the National Institutes of Health included work with Nobel Laureate and medical anthropologist Carleton Gajdusek. She later served as a brain tumor clinical trials leader and Chair of a Cancer Institutional Review Board at Weill Cornell Medicine. She is also an inventor on a U.S. patent for mixed-reality systems designed to enhance stereotactic radiosurgery treatment planning. A committed educator and mentor, Dr. Pannullo received Weill Cornell Medicine’s Robert G. Schwager, MD ’67 Education Scholar Award. Her national leadership has included service on the Boards of Directors of the National Brain Tumor Society and the American Association of Neurological Surgeons. She serves as Chair of the Board of Trustees of The Washington Center in Washington, DC. Her South Florida activities include membership in the Miami Biotech Collective and participation in Biotech Miami, reflecting her growing engagement with the region’s neuroscience, biotechnology, and innovation community. Dr. Pannullo was recently elected to the Board of Directors of the Society for Brain Mapping and Therapeutics and serves as Co-Chair of the Local Organizing Committee for Neuroscience20 (N20) in Miami, bringing together her longstanding interests in neuroscience, biotechnology, engineering, education, and multidisciplinary innovation.

Portrait of Michael Y. Wang Co-Chair

Neurosurgery & Minimally Invasive Spine Surgery

Michael Y. Wang MD, MBA, FACS, FAANS

Full profile

Chief of Neurosurgery at the University of Miami Hospital, Professor with Tenure in the Departments of Neurological Surgery and Rehabilitation Medicine, and Spine Neurosurgery Fellowship Director at the University of Miami Miller School of Medicine. A Phi Beta Kappa graduate of Stanford University who earned both his BS and MD there, he completed his neurosurgery residency at USC and LA County General Hospital and a spine fellowship at the University of Miami under Barth Green and Allan Levi. He then served as Spine Program and Fellowship Director at USC before moving to Miami in 2007. A pioneer in minimally invasive spine surgery, he has held leadership roles across the AANS Board of Directors, the North American Spine Society, the Society of University Neurosurgeons, and the International Society for the Advancement of Spine Surgery. He sits on editorial boards including Neurosurgery, World Neurosurgery, and the Journal of Neurosurgery: Spine, and has helped patients ranging from complex multilevel revision cases to a young gunshot victim regain the ability to walk.

KEY OPINION LEADERS

Key Opinion Leaders

Distinguished leaders and high-level invitees associated with the 2026 N20 Miami program.

Portrait of Dr Patrick Soon-Shiong
Key Opinion Leader

Dr Patrick Soon-Shiong

Physician, surgeon, scientist, inventor, technologist and healthcare entrepreneur; Chairman and CEO of NantWorks, with work spanning cancer therapeutics, biotechnology and healthcare technology.

NantWorks ↗
Official portrait of Dr Mehmet Oz
To Be Confirmed

Dr Mehmet Oz

Cardiothoracic surgeon and CMS Administrator. He received his MD and MBA from the University of Pennsylvania and is Professor Emeritus at NewYork-Presbyterian/Columbia Medical Center. His N20 Miami participation remains listed as To Be Confirmed.

Official CMS profile ↗
Portrait of Dr Robert J. Hariri
Key Opinion Leader

Dr Robert J. Hariri

Surgeon, biomedical scientist and entrepreneur; Chairperson, Founder and CEO of Celularity and a pioneer in cellular and regenerative medicine.

Celularity profile ↗
Portrait of Dr Kasif Nevzat Tarhan
Key Opinion Leader

Dr Kasif Nevzat Tarhan

Professor of Psychiatry and President/Rector of Üsküdar University, Istanbul, with leadership spanning psychiatry, neuropsychology, mental health, education and global neuroscience collaboration.

Üsküdar University ↗
Portrait of Dr Denis Fedorenko
Key Opinion Leader

Dr Denis Fedorenko

MD, PhD, DSc and Professor of Hematology and Stem Cell Therapy at the National Medical and Surgical Center named after N.I. Pirogov in Moscow, with expertise in autologous HSCT and autoimmune disease.

Professional profile ↗
Portrait of Dr Shinichiro Akiyama
Key Opinion Leader

Dr Shinichiro Akiyama

Medical oncologist and translational cancer researcher; Director of the Tokyo Cancer and Intractable Disease Support Center and Natural Medica Japan, with work spanning oncology, regenerative medicine and gene-editing approaches.

N20 Program Profile ↗
SBMT EXECUTIVE PROTOCOL

SBMT Executive Protocol Team

Executive protocol, on-ground coordination, accommodation, press, marketing and public-relations leadership for N20 Miami.

Portrait of Dr Giridhar Solasa, MD — Chief Protocol Officer
Chief Protocol Officer

Dr Giridhar Solasa, MD

Research Scientist and Senior Program Officer with the Society for Brain Mapping and Therapeutics, with a medical background and work spanning clinical neuroscience, evidence-based medicine and healthcare AI.

Professional profile ↗
Portrait of Mayra Castañeda
On-Ground Protocol Officer

Ms Mayra Castañeda

Operational role supplied for the N20 Miami summit. No sufficiently reliable public biography or photo source was located, so no unsupported biography has been invented.

LinkedIn profile ↗
Portrait of Bryan Aroz
Global Director of International Events

Mr Bryan Aroz

Hospitality professional with most of his career spent representing leading hotel brands in the Sales department in India. His experience handling corporate business has strengthened his growth potential, relationship management, and networking skills. His hospitality industry background has further supported the growth of his HelmsBriscoe business while maintaining relationships with domestic and international clients, and has given him a broader understanding of how the hospitality industry operates on an international platform.

SBMT staff record ↗
Portrait of Dr. Ana Isabel Alves da Cunha
Director of International Events

Dr. Ana Isabel Alves da Cunha

Dr. Ana Isabel is Director of the Membership Committee of the Society for Brain Mapping and Therapeutics Brazil (SBMT), Director of the Brazilian Epilepsy Federation, Director of International Events for SBMT, and CEO of Hangar 7 Eventos.

Full profile

With 20 years of experience in the international market, she leads the direction and production of major neuroscience events, including the TEA Global Congress. She also serves as Director of Institutional Events, with particular emphasis on her work with the Brazilian Air Force Aerospace Museum.

She is also dedicated to raising awareness of epilepsy, autism, and rare diseases. Her experience, technical expertise, and extensive network of relationships are key differentiators reflected in the quality and results of the projects under her responsibility.

LinkedIn profile ↗
Portrait of Kortni Gilson
Press Officer

Ms Kortni Gilson

Actress and television personality known as a cast member of MTV’s Floribama Shore; she serves N20 Miami as Press Officer for SBMT.

Public profile ↗
Portrait of Arifa Kokab
Marketing & PR Head

Ms Arifa Kokab

Computational neuroscience and neuromorphic AI engineer and biomedical neuroscience researcher. She leads marketing, communications and entrepreneurial strategy across SBMT, WBMF and BTIP and is Scientific Founder & CEO of The Neurobusiness Corporation.

Professional profile ↗
Profile avatars are served via Unavatar
N20 Archive

Communiqués, Legislations & Publications

Selected N20 communiqués, legislations, publications, resolutions and related official records. Each document is shown as a live preview and opens the official World Brain Mapping website document in a new tab.

Official Sponsorship Information

N20 Sponsorship Prospectus

Organizations interested in supporting the 13th Annual Neuroscience20 Summit can review the official sponsorship prospectus below.

ABOUT

About the Neuroscience20 Summit

Neuroscience20 (N20) is the global policy summit convening leaders in brain, spine, and mental health across G20 nations. N20 is a joint initiative of the Society for Brain Mapping & Therapeutics and the World Brain Mapping Foundation, combining SBMT’s scientific and clinical leadership with WBMF’s nonprofit mission of education, global collaboration, public awareness, patient impact and public-benefit brain health advancement.

The summit brings together policymakers, scientists, engineers, physicians, surgeons, universities, investors, and globally recognized research institutions to advance the development and deployment of clinical solutions for neurological disorders, conditions that affect more than three billion people and cost the global economy hundreds of billions of dollars annually.

Through this joint structure, N20 serves both as a high-level scientific and policy convening platform and as a mission-driven WBMF program supporting education, collaboration and patient-centered translation in brain, spine and mental health.

REQUEST INFORMATION

Connect with the Neuroscience20 Miami team

Share your interest in Neuroscience20 Miami 2026 and our team will route your request to the right contact for attendance, speaking, partnership, sponsorship, donor, or media follow-up.

AttendSpeakPartnerSponsorDonateMedia
A DECADE OF GLOBAL CONVERGENCE

Thirteen Years. Thirteen Cities. One Global Conversation.

The N20 Summit has convened across G20 capitals since 2014, driving cross-border policy alignment and translational research collaboration. Miami marks the 13th annual summit and the second U.S. host city in the program’s history.

N20 Summit host cities, 2014 to 2026 world map N20 · #1 BRISBANE · 2014 N20 · #2 ISTANBUL · 2015 N20 · #3 HANGZHOU · 2016 N20 · #5 BUENOS AIRES · 2017 N20 · #6 OSAKA · 2018 N20 · #7 · VIRTUAL RIYADH · 2019 N20 · #8 · VIRTUAL ROME · 2020 N20 · #9 BALI · 2021 N20 · #10 NEW DELHI · 2022 N20 · #11 RIO DE JANEIRO · 2023 N20 · #12 JOHANNESBURG · 2024 N20 · 13TH ANNUAL MIAMI · 2026 N20 · #14 · UPCOMING HAMBURG · 2027
SUMMIT AGENDA

Topics & Goals

Explore the N20 agenda without adding unnecessary page length.

Official Summit Agenda Topics
01

Brain Mapping & Therapeutics

Imaging, connectivity, and image-guided intervention

02

Neurotechnology Innovation & Investment

The pipeline from lab to clinic, and the capital that moves it

03

Artificial Intelligence in Neuroscience

AI for diagnosis, imaging, and therapeutic decision support

04

Neuro-Imaging

Structural and functional imaging at clinical scale

05

Vascular Neurosurgery

Stroke, aneurysm, and cerebrovascular intervention

06

Neuro-Oncology

Brain tumor diagnosis, surgery, and combination therapy

07

Mental Health Disorders

Depression, anxiety, and major mental illness at scale

08

PTSD & Trauma

Post-traumatic stress across civilian and military populations

09

Suicide Prevention

Risk stratification, intervention, and policy frameworks

10

Opioid Addiction

The ongoing pandemic and neurobehavioral interventions

11

Epilepsy

Surgical, pharmacologic, and device-based approaches

12

Spine

Spinal disease, intervention, and rehabilitation

13

Neurodegenerative Disease

MS, ALS, Parkinson’s, and Alzheimer’s research

14

Traumatic Brain Injury (TBI)

Acute care, rehabilitation, and long-term outcomes

15

Spinal Cord Injury

Restoration, neuroprosthetics, and rehabilitation

16

Regulatory & Policy Frameworks

FDA, EMA, and cross-border neurotechnology policy

GLOBAL POLICY OBJECTIVES

Goals of Neuroscience20

Official N20 Policy ObjectivesGoals of Neuroscience20
01

Build a global alliance for brain, spine and mental health/illness.

02

Encourage a consortium approach to research and development.

03

Advocate for global harmonization of related policies and standardization of data.

04

Encourage neuro-economic assessment of the future impact of disease, diagnostics and prevention.

05

Facilitate translation and commercialization of technologies across disciplines to rapidly identify and introduce next-generation therapeutics.

06

Advocate for unifying global regulations and guidelines on clinical trials and drug/device-combination discovery.

07

Advance innovation in brain, spine, and mental health through global partnerships and new funding initiatives across academia, industry, nonprofits, and government.

08

Integrate nanotechnology, artificial intelligence, virtual/augmented reality, supercomputing, multimodality brain mapping/imaging, cellular therapeutics, neurophotonics, and devices to fast-track innovation and reduce healthcare delivery costs.

09

Bring global brain and spine initiatives together to identify best clinical and basic-science practices and create a united front for effective therapeutics.

10

Set unified standards for training, prevention, care, and advanced therapeutics across the clinical neuroscience workforce.

11

Provide local, regional, and national capabilities to advance clinical neuroscience practice through advocacy and engagement with health ministries and government programs.

12

Advocate for global research and innovation funding for brain, spine, and mental health.

13

Facilitate investment and commercialization of neurotechnologies for brain, spine, and mental health/illness.

14

Educate professionals, patients, and families about the state of science, technology, innovation, and policy in clinical neuroscience.

15

Provide accurate, up-to-date resources and data to governments of G20 nations and beyond to support evidence-based clinical neuroscience policy.

16

Spread awareness and support prevention and intervention for mental and psychological health challenges, including PTSD, anxiety, stress, and suicide prevention.

Hotel & Travel

Enjoy the SBMT company rate at Pullman Miami Airport

Stay close to the summit with a preferred company booking offer for Society for Brain Mapping and Therapeutics travelers. Use the direct Accor reservation link below; the client and access codes are already included in the booking URL.

SAVE THE DATE

DECEMBER 13

2026
MIAMI · FLORIDA · USA
27 28 29